Trials / Completed
CompletedNCT01003080
Unipolar vs. Bipolar Hemostasis in Total Knee Arthroplasty: A Prospective Randomized Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 111 (actual)
- Sponsor
- Montefiore Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The use of Aquamantys during total knee arthroplasty will reduce drain output and the necessity for blood transfusions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Aquamantys Device | The Aquamantys is used for hemostasis in patients randomized to receive total knee arthroplasty with the device. |
| OTHER | Standard of care treatment for hemostasis during a total knee arthroplasty. | The active comparator arm will receive the "standard-of-care" for hemostasis during total knee arthroplasty. This is achieved with a unipolar Bovie electrocauterization device. |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2010-04-01
- Completion
- 2010-04-01
- First posted
- 2009-10-28
- Last updated
- 2018-09-21
- Results posted
- 2011-04-07
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01003080. Inclusion in this directory is not an endorsement.